ArticleMayo Clinic proceedings. Innovations, quality & outcomes2026
Sex of the Treating Rheumatologist and Disease Activity Outcomes in Psoriatic Arthritis.
Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess whether the sex of the treating rheumatologist is associated with longitudinal disease activity trajectories in patients with psoriatic arthritis (PsA). Patients and Methods: We conducted a longitudinal registry-based study including 712 patients with PsA followed from 26 September 2014 to 23 December 2019 and classified by rheumatologist sex at baseline. The primary outcome was change from baseline in 28-joint disease activity score based on C-reactive protein (DAS28-CRP) (n=588) and ankylosing spondylitis disease activity score based on C-reactive protein was secondary (n=452). Missing baseline covariates were multiply imputed. Baseline imbalances were addressed using inverse probability of treatment weighting based on outcome-specific propensity scores. Longitudinal associations were estimated using inverse probability of treatment weighting-weighted generalized estimating equations with spline modeling of time and pooled using Rubin's rules. Results: Patients (410/712 [57.6%] managed by male and 302/712 [42.4%] by female rheumatologists) had a median follow-up of 3.4 years. At 12 months, the pooled difference in ΔDAS28-CRP (women-men) was -0.08 (95% CI, -0.37 to 0.20; Conclusion: In this real-world PsA cohort, rheumatologist sex was associated with a modestly greater mean DAS28-CRP improvement at 24 months, mainly driven by joint counts.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.